Before the Senate Committee on Aging, former general counsel and senior business executive of Turing Pharmaceuticals, Howard Dorfman, testified today that the closed...
Read More
“When Turing acquired Daraprim®, it also assumed the distribution channels, organizational decisions, and contracts that its predecessor, Impax, had put in place....
Read MoreThere are 2 factors that now limit access to Turing Pharmaceutical’s Daraprim, a major and often-preferred component of treatment for toxoplasmosis: 1) its (at...
Read More
If you’re breathing air, you’re very likely to know that, in August, Turing Pharmaceuticals increased the list price of its newly purchased brand-name...
Read MoreForbes’s Matthew Herper on Bill Gates on vaccines and pharma: There’s sufficient ink for undeniably venerable ideas and acts, but an...
Read More
There are journalistic programs in which we (I) place more credit than others—possibly owing to their style, possibly owing to their length and supposed care with a...
Read More